Skip to main content
. 2025 Apr 17;13(4):981. doi: 10.3390/biomedicines13040981

Figure 2.

Figure 2

The structures of Pt anticancer drugs: (a) cisplatin; (b) tetrachloro(DL-trans-1,2-diaminocyclohexane)platinum(IV) or ormaplatin/tetraplatin; (c) cis,cis,trans-[Pt(i-PrNH2)2Cl2(OH)2] or iproplatin; (d) cis,cis,trans-[Pt(NH3)2Cl2(OH)2] or oxoplatin.